Medicines that treat or manage secondary conditions arising from, relating to and complicated by underlying serious, chronic and long-term diseases.
Medicines and Medical Devices that treat or manage conditions related to sexual and reproductive health in both women and men.
Healthcare products that manage or treat common conditions that can be self-treated or managed with the assistance of healthcare professionals.
Kora Healthcare is a fully integrated healthcare company with core competencies across Research, Development & Innovation, Scientific & Medical Affairs, Regulatory Affairs & Pharmacovigilance, Quality, Supply Chain, Marketing & Sales, Finance and Customer Services. All departments are led from our headquarters in Dublin, Ireland with UK sales and marketing operations located in York, UK.
Kora Healthcare is accredited and certified to Good Manufacturing Practice, Good Distribution Practice, ISO 13485 and holds a manufacturing license and wholesale license for product portfolio assets and an importation license (DEL) in Canada. Kora Healthcare operates under a virtual manufacturing platform in that Kora Healthcare manufactures through an established network of contract manufacturing organisations and contract research organisations for development and commercial manufacturing.
Kora Healthcare operates broadly along two business models:
Our ‘Home Markets’ model supported by our established infrastructure across the UK, Ireland and Germany involves a mix of internally developed portfolio products and in-licensed products.
Our ‘International Markets’ model, by contrast, is focussed on developing long-term licensee’s and distributors with a like-minded therapy focus across global markets, supported by our internal team.
As a business we are resourced and optimally-sized to delivery continued growth for several years from our portfolio of currently marketed products, coupled with multiple opportunities for continued geographical expansion anticipating the delivery on our product development pipeline. Our development pipeline builds on existing therapeutic areas of focus and lifestyle brands of the patients and consumers we serve.
Our current priorities include optimising the international market expansion of ready –to-market, Magnaspartate and increasing the global footprint of brands such as Relactagel and Regelle. Together with our international focus, we continue to ensure launch readiness for our ever-evolving research, development and innovation pipeline.
Contact Kora Healthcare:
At Kora Healthcare, we strive to build a sustainable, growth-orientated and value-driven business through delivery of a robust product portfolio and pipeline. By fostering a culture of innovation and quality, we will continue to anticipate, understand and respond to patient needs efficiently and effectively.
The Kora Healthcare Leadership combines commercial and technical experience that spans decades of senior leadership across the pharmaceutical and medical device industry. By fostering a culture of innovation and quality our leadership team is focussed on building sustainable, growth-orientated and value-driven business.
We are seeking to engage with external partners, identify, develop and commercialise healthcare products international and to fully realise the potential and value of our established company infrastructure.
Chief Executive Officer
Working with Kora Healthcare since 2010 across commercial functions, Conor O’Daly became a Chief Executive Officer in August 2016. Prior to joining Kora Healthcare, Conor worked with a then sister company to Kora Healthcare, Newport Pharmaceuticals. Conor holds a BA in International Business (Finance) with languages and subsequently completed a number of post-graduate diplomas across commercial disciplines. Conor also is an executive director on the Kora Healthcare Board of Directors.
Commercial Director (UK ethical)
Working with Kora Healthcare since 2009 Mark has over 30 years of pharmaceutical and nutrition industry experience. Mark strives to ensure maximum sales growth and long term return on investment for Kora UK and its product portfolio through the development and optimisation of its sales teams, marketing approaches and customer macro influencers.
Commercial Director - ROI & ROW
Shane Fitzgerald is a life science graduate and pharmaceutical industry professional with many years of experience across multiple therapy classes. Shane has launched many new chemical entities, biologics and biosimilar agents in multiple international markets. Shane is insightful marketeer with a specific focus on market access solutions for new product launches, meeting the needs of patients, prescribers and payers. Committed to customer focus, Shane has keen focus on innovation, operational excellence and collaboration to improve clinical outcomes. Before coming to join Kora Healthcare, Shane enjoyed a successful career at many internal companies including, MSD Human Health Ireland, Pfizer Healthcare Ireland, Biogen Idec, and Servier Laboratories.
Group Financial Controller
Richard was appointed the Financial Controller of Kora Corporation in 2019, where he oversees the accounting, financial planning, and analysis, treasury, audit and tax functions at Kora. He was Finance Director of 2468 Group from 2016 to 2019 where he was responsible for a Finance and M&A activity of the group. Prior to joining 2468 Richard worked in Bostik Industries and worked in a number of finance roles with Bostik from 2006 to 2016. He is a qualified accountant and holds a bachelors degree in Management Information Systems from St John Moore’s University Liverpool and a Professional Certificate in Management from Open University.
Scientific & Medical Affairs Manager
Sinead has responsibility for Development, Manufacturing Support and Medical Affairs at Kora Healthcare. Sinead worked for 10 years at Abbott Diagnostics in technical leadership roles in quality, product technical support and validation. Sinead also worked as a Cell Culture Manager, responsible for the upstream commercial production of recombinant Follicle Stimulating Hormone (FSH). Sinead graduated with a degree in Industrial Biochemistry from the University of Limerick and earned a Ph.D. in Cell Biology /Immunology from Trinity College Dublin, and went on to work as a post-doctoral researcher in the areas of colon cancer and asthma.
Annette holds a B.Sc in Industrial Biology, Higher Diploma in Pharmaceutical production and Food Science, Annette has 20 years experience across Medical Device and Pharmaceutical Industry and gained valuable experience while working in a number of areas including Analytical Chemistry, Validation and Quality before joining the Quality team at Kora in 2015. Annette has previously worked in Multi-national organisations including Pfizer, MSD, Leo Pharma and BD Medical bringing a wide range of varied experience to the management of the Quality System at Kora. Green Belt Certified and Lead Auditor trained Annette has successfully lead a number of Notified Body Audits at Kora.
Head of Asia-Pacific and US
Will leads the expansion of Kora Healthcare into North America, based in Ontario Canada he will be responsible for providing leadership & strategic direction to the US, Canadian and Asian markets.Driving high standards of performance to deliver growth and enhance customer relationships.
Will holds more than 22 years of international experience within some of the world’s largest healthcare companies. Will has delivered business start-ups, accelerations, demonstrated success in high-growth emerging markets. He has held senior positions including Vice President of Medical Solutions at Waterwipes for Asia-Pacific & Emerging Markets, Ethical Lead for Pfizer Nutrition in Ireland and Head of Commercial operations for Nestle Nutrition UK&I.
Regulatory Affairs & PV Manager
Helen Crowley is a graduate of Trinity College Dublin with a BA (Mod) in Microbiology. Helen has amassed over 20 years’ experience in the pharmaceutical, biopharmaceutical, medical device, and food supplement industries.
She has previously worked for Mallinckrodt Veterinary, Howmedica (Stryker Orthopaedics), MSD and Noden Pharma DAC across a range of both Quality and Regulatory Affairs roles. Within Kora Healthcare Helen is responsible for the strategic registration and ongoing compliance of medicinal products and medical devices across the EU, non-EU, and North American territories.
Venkata Naresh Kumar Vanga
Research & Development Manager
Naresh has valuable experience of working in the pharmaceuticals industry for over 15 years in various departments (mainly R&D) as Research associate, Lead formulation scientist, Analytical chemist, Senior/Principal professional (Global MSAT) and Global formulation development Manager. Naresh is Lean Six Sigma Black Belt certified and proficient in pharmaceutical formulation development, Deconstruction, Analytical method development/validation, technical transfers, Project management, Root cause investigations and troubleshooting (early & late-stage development). Naresh holds Masters in Pharmaceutical formulation science and Master’s in Business Administration (MBA).
As R&D Manager, Naresh is responsible for leading and managing the R&D team as part of Research, Development, and Innovation function within Kora healthcare. As a key member of R&D/Innovation function, Naresh is also responsible for promoting a culture of Innovation, internal product development pipeline, early-stage/late-stage product development and providing technical support to cross functional departments such as Regulatory Affairs and Quality.
Global Supply Chain Manager
Niall joined the team in 2022, bringing over 20 years of end-to-end Supply Chain experience in Life Sciences. This has included both internal and external manufacturing, while working for a range of companies from small start-ups to major multinationals. He has managed small volume products for Rare Disease treatment right up to multi-billion-dollar Blockbuster products, mainly within the Pharmaceutical sector but also Medical Device, Medical Technology, Bio-Pharmaceutical and Gene Therapy sectors.
Niall holds a B. Tech in Production Management, an M. Sc. In Supply Chain Management and is Green Belt certified in Lean / 6 Sigma
Board of Directors
The Kora Healthcare Board of Directors provides the leadership, guidance and governance necessary to execute our mission, vision and strategy now and into the future.
Darren Cunningham | Chairman
Shauna Lord | Non-Executive Director
Clodagh Kelly | Non-Executive Director
- Conor O’Daly | Executive Director
Kora Healthcare is a 100% privately owned healthcare company and a subsidiary of Immdal Ltd Group.
The Immdal Ltd Group consists of Kora Healthcare and Immcell Ltd, a sister company to Kora Healthcare, and is wholly owned by the O’Daly family. Immdal Ltd seeks to develop additional commercial subsidiaries with growth potential capable of delivering regular income and profits to the group including but not limited to; biotechnology, finished pharmaceuticals, novel technology platform, active ingredients across both food and pharmaceuticals, animal health, bio-marine products, renewable and sustainable energies and commercial property.